Eli Lilly’s Zepbound, on high of older drug, diminished psoriatic arthritis signs
Eli Lilly stated Thursday that including its weight reduction drug Zepbound on high of its immunology remedy Taltz helped overweight sufferers with an autoimmune situation that causes joint ache greater than Taltz did alone.
The info counsel the GLP-1 drug Zepbound, which has already been proven to assist with weight problems and sleep apnea, amongst different situations, may additionally be useful for psoriatic arthritis, or PsA.
Nevertheless it’s not clear if these outcomes can have a big impression on prescribing patterns for Lilly’s medicine, on condition that there’s already big demand for Zepbound because of its important weight reduction results.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day protection and evaluation of the pharma business — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
